Paragon Ventures I Invests in Singapore-based biotech start-up; Insectta, to begin industrialisation of patented insect biomaterial extraction technology
Ethan Lim joins as Advisor, Discretionary Portfolio Management, William Goh joins as Vice President and Portfolio Manager, Both bring with them strong track records in wealth management.
Paragon SAGE offers investors exposure to quality global companies SINGAPORE, 8 December 2021 – Bespoke wealth manager Paragon Capital Management Singapore (“PCMS” or “the Company”) has expanded its fund offering for accredited investors with the new Paragon Systematic Advantage Global Equity fund (“Paragon SAGE”), an open-ended, equity-focused fund that aims to provide long-term capital growth […]
Bespoke wealth manager Paragon Capital Management Singapore (“PCMS” or “the Company”), has launched Paragon Ventures I, an early-stage venture capital fund that invests in productivity and efficiency enablers from the pre-seed to series A development stages. The launch of this fund forms part of the Company’s strategy to broaden its product proposition to clients.
Confirmation of Accredited Investor Status and Consent to the Terms of Use and Privacy & Cookies Policy
I confirm that I am an “Accredited Investor”, “Institutional Investor” or “Expert Investor” as defined under the Securities and Futures Act (Chapter 289) and Securities and Futures (Classes of Investors) Regulations 2018 of Singapore and qualify as such under one of the categories.
I have reviewed and hereby agree to the Terms of Use and Privacy & Cookies Policy for accessing this Website.
